Deregulation of Lipid Metabolism: The Critical Factors in Ovarian Cancer

Frontiers in Oncology
Zhaodong JiGong Yang

Abstract

Ovarian cancer is one of the most malignant gynecological cancers around the world. In spite of multiple treatment options, the five-year survival rate is still very low. Several metabolism alterations are described as a hallmark in cancers, but alterations of lipid metabolism in ovarian cancer have been paid less attention. To explore new markers/targets for accurate diagnosis, prognosis, and therapeutic treatments based on metabolic enzyme inhibitors, here, we reviewed available literature and summarized several key metabolic enzymes in lipid metabolism of ovarian cancer. In this review, the rate limiting enzymes associated with fatty acid synthesis (FASN, ACC, ACLY, SCD), the lipid degradation related enzymes (MAGL, CPT, 5-LO, COX2), and the receptors related to lipid uptake (FABP4, CD36, LDLR), which promote the development of ovarian cancer, were analyzed and evaluated. We also focused on the review of application of current metabolic enzyme inhibitors for the treatment of ovarian cancer through which the potential therapeutic agents may be developed for ovarian cancer therapy.

References

May 22, 2003·Journal of the National Cancer Institute·Yu-Long HuRobert B Jaffe
Jul 20, 2004·Journal of Cellular Biochemistry·Makiko Umezu-GotoGordon B Mills
Sep 15, 2004·Molecular Aspects of Medicine·Jean-Paul BonnefontJean Bastin
May 19, 2006·Cancer Research·Véronique ChajèsVirginie Joulin
Jun 17, 2006·Current Opinion in Clinical Nutrition and Metabolic Care·Johannes V SwinnenGuido Verhoeven
Oct 31, 2006·Human Reproduction Update·Peter C K Leung, Jung-Hye Choi
Sep 7, 2007·Clinical Nutrition : Official Journal of the European Society of Parenteral and Enteral Nutrition·E L DillonMelinda Sheffield-Moore
Sep 21, 2007·Nature Reviews. Cancer·Javier A Menendez, Ruth Lupu
Nov 22, 2007·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·P M WojnarowiczP N Tonin
Apr 19, 2008·Reproductive Sciences·Rodney P RocconiWarner K Huh
Dec 3, 2008·Journal of Lipid Research·Salih J Wakil, Lutfi A Abu-Elheiga
Jul 9, 2009·Physiological Reviews·Gregory R Steinberg, Bruce E Kemp
Sep 4, 2009·Annual Review of Entomology·Estela L Arrese, Jose L Soulages
Oct 12, 2010·Free Radical Biology & Medicine·Jerry A SaundersLarry W Daniel
Jun 28, 2011·Biochimica Et Biophysica Acta·Eoin FahyShankar Subramaniam
Sep 29, 2011·Molecular Cancer Research : MCR·Urvashi V RoongtaBrent A Rupnow
Nov 1, 2011·Nature Medicine·Kristin M NiemanErnst Lengyel
Jan 3, 2012·Advances in Nutrition·Xueqing LiuJames M Ntambi
Sep 25, 2012·Progress in Lipid Research·Leanne Hodson, Barbara A Fielding
Feb 22, 2013·Nature Reviews. Cancer·Emma KippsStan B Kaye
Mar 1, 2013·Nature Reviews. Cancer·Arkaitz CarracedoPier Paolo Pandolfi
Jun 5, 2013·Molecular Medicine Reports·Shu LiWen Di
Jun 25, 2013·Cell Metabolism·Erin CurrieRobert V Farese
Jan 28, 2014·Journal of Receptor and Signal Transduction Research·Toshifumi TsujiuchiNobuyuki Fukushima
Oct 11, 2014·International Journal of Cancer. Journal International Du Cancer·Daniel VeigelThomas W Grunt
Oct 17, 2014·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Joyce Liu, Ursula A Matulonis
May 8, 2015·Journal of Translational Medicine·Dirk O BauerschlagKaren Bräutigam
Aug 25, 2015·Redox Biology·Ryuichi Mashima, Torayuki Okuyama
Jan 16, 2016·Cell Metabolism·Natalya N Pavlova, Craig B Thompson
Aug 24, 2016·Biochimica Et Biophysica Acta·Andreas KoeberleMaria Thürmer

❮ Previous
Next ❯

Methods Mentioned

BETA
histone acetylation
ubiquitination
deubiquitination
xenograft
chip

Related Concepts

Related Feeds

Cancer Metabolic Reprogramming (Keystone)

Cancer metabolic reprogramming is important for the rapid growth and proliferation of cancer cells. Cancer cells have the ability to change their metabolic demands depending on their environment, regulated by the activation of oncogenes or loss of tumor suppressor genes. Here is the latest research on cancer metabolic reprogramming.

Cancer Metabolic Reprogramming

Cancer metabolic reprogramming is important for the rapid growth and proliferation of cancer cells. Cancer cells have the ability to change their metabolic demands depending on their environment, regulated by the activation of oncogenes or loss of tumor suppressor genes. Here is the latest research on cancer metabolic reprogramming.